Skip to main content

Supreme Court seeks Centre’s response on unethical clinical trials in Gujarat

By A Representative 
The Supreme Court of India on Tuesday directed the Union Government to respond to serious allegations regarding unethical and illegal clinical trials conducted in Ahmedabad and other parts of the country. The directive came while hearing a Public Interest Litigation (PIL) filed by Swasthya Adhikar Manch (SAM), which exposed the exploitation of vulnerable populations in drug trials.
Senior advocate Sanjay Parikh, representing the petitioners, told the court that approximately 500 patients were subjected to clinical trials in a public hospital managed by the Ahmedabad Municipal Corporation. These trials, allegedly conducted without mandatory oversight by an Ethics Committee as required under the New Drugs and Clinical Trials Rules, 2019, involved 58 pharmaceutical companies—both national and international—since 2021.
According to the petition, private drug companies allegedly transferred Rs 17 to 20 crore into the personal accounts of doctors involved in the trials. Meanwhile, trial participants were paid meagre sums between Rs 200 to Rs 500 and reportedly received no compensation in cases of death or serious adverse effects (SAEs). Between 2005 and 2020, India recorded 34,390 cases involving clinical trial-related deaths and SAEs, including 6,500 deaths.
Activists from across the country also raised alarms. ND Jayprakash noted that survivors of the Bhopal Gas Tragedy were exploited in similar trials in Bhopal, resulting in multiple deaths and SAEs. In Indore, some doctors allegedly earned over Rs 5 crore while conducting unethical trials, with 81 adverse events reported. In Rajasthan, out of 213 clinical trials, 95 deaths were recorded, including several in Jaipur in 2018.
The Supreme Court instructed the Government to respond specifically to the affidavit filed on April 23, 2025, by Swasthya Adhikar Manch, and address multiple issues raised regarding clinical trial regulation.
Amulya Nidhi of SAM stated that the organization, in collaboration with Jan Swasthya Abhiyan India, Rajasthan Nagrik Manch, Drug Trial Peedit Sangh, and others, would continue its campaign to ensure justice for clinical trial victims.

Comments

Post a Comment

NOTE: Hateful, abusive comments won't be published. -- Editor

TRENDING

Small Farm, big success: How an innovative couple built a model of sustainable farming

By Bharat Dogra  In Sema, a remote village in Rajasthan's Rajsamand district, Bhagwati Lal and his wife Rekha share equal credit for creating a remarkable farm that has become an inspiration for villagers and visitors alike. Their achievement demonstrates how even a very small piece of land can provide a strong foundation for sustainable livelihoods while enhancing climate resilience and protecting the environment.
Post a Comment
»

Incarceration of Prof Saibaba 'revives' the question: What is crime, who is criminal?

By Kunal Pant* In 2016, a Supreme Court Judge asked the state of Maharashtra, “Do you want to extract a pound of flesh?” The statement was directed against the state for contesting the bail plea of Delhi University Professor GN Saibaba. Saibaba was arrested in 2014, a justification for which was to prevent him from committing what the police called “anti-national activities.”
Post a Comment
»

Shrinking settlements, fading schools: The Tibetan exile crisis in India

By Tseten Lhundup*  Since the 14th Dalai Lama fled to India in 1959, the Tibetan exile community in Dharamsala has established the Central Tibetan Administration (CTA) as the guardian of Tibetan culture and identity. Once admired for its democratic governance , educational system , and religious vitality , the exile community now faces an alarming demographic and institutional decline. 
Post a Comment
»